Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Neeb

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
European Journal of Neurology|July 25, 2023
Near-death experiences are associated with rapid eye movement (REM) sleep intrusions in migraine patients, independent of migraine auraBianca Raffaelli, Pia Kull, Jasper Mecklenburg, et al.
Frontiers in Neurology|July 5, 2022
Study Design and Protocol of a Randomized Controlled Trial of the Efficacy of a Smartphone-Based Therapy of Migraine (SMARTGEM)Ana Sofia Oliveira Gonçalves, Inga Laumeier, Maxi Dana Hofacker, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2012
Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic statePhilipp Mergenthaler, Anja Kahl, Anne Kamitz, et al.
European Journal of Radiology|June 3, 2018
Homogeneous application of imaging criteria in a multicenter trial supported by investigator training: A report from the WAKE-UP studyIvana Galinovic, Volker Dicken, Johannes Heitz, et al.
Schmerz (Berlin, Germany)|January 20, 2023
[Erratum to: Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]Gudrun Goßrau, Stefanie Förderreuther, Ruth Ruscheweyh, et al.
Der Nervenarzt|January 16, 2023
[Erratum to: Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]Gudrun Goßrau, Stefanie Förderreuther, Ruth Ruscheweyh, et al.
Der Nervenarzt|October 26, 2022
[Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]Gudrun Goßrau, Stefanie Förderreuther, Ruth Ruscheweyh, et al.
Schmerz (Berlin, Germany)|October 26, 2022
[Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]Gudrun Goßrau, Stefanie Förderreuther, Ruth Ruscheweyh, et al.
The New England Journal of Medicine|May 17, 2018
MRI-Guided Thrombolysis for Stroke with Unknown Time of OnsetGötz Thomalla, Claus Z Simonsen, Florent Boutitie, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
European Journal of Neurology|July 25, 2023
Near-death experiences are associated with rapid eye movement (REM) sleep intrusions in migraine patients, independent of migraine auraBianca Raffaelli, Pia Kull, Jasper Mecklenburg, et al.
Frontiers in Neurology|July 5, 2022
Study Design and Protocol of a Randomized Controlled Trial of the Efficacy of a Smartphone-Based Therapy of Migraine (SMARTGEM)Ana Sofia Oliveira Gonçalves, Inga Laumeier, Maxi Dana Hofacker, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2012
Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic statePhilipp Mergenthaler, Anja Kahl, Anne Kamitz, et al.
European Journal of Radiology|June 3, 2018
Homogeneous application of imaging criteria in a multicenter trial supported by investigator training: A report from the WAKE-UP studyIvana Galinovic, Volker Dicken, Johannes Heitz, et al.
Schmerz (Berlin, Germany)|January 20, 2023
[Erratum to: Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]Gudrun Goßrau, Stefanie Förderreuther, Ruth Ruscheweyh, et al.
Der Nervenarzt|January 16, 2023
[Erratum to: Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]Gudrun Goßrau, Stefanie Förderreuther, Ruth Ruscheweyh, et al.
Der Nervenarzt|October 26, 2022
[Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]Gudrun Goßrau, Stefanie Förderreuther, Ruth Ruscheweyh, et al.
Schmerz (Berlin, Germany)|October 26, 2022
[Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]Gudrun Goßrau, Stefanie Förderreuther, Ruth Ruscheweyh, et al.
The New England Journal of Medicine|May 17, 2018
MRI-Guided Thrombolysis for Stroke with Unknown Time of OnsetGötz Thomalla, Claus Z Simonsen, Florent Boutitie, et al.
Pageof 7